{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:35:33Z","timestamp":1789022133877,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,22]]},"DOI":"10.7759\/cureus.99865","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T21:30:42Z","timestamp":1766439042000},"source":"Crossref","is-referenced-by-count":2,"title":["Glucagon-Like Peptide-1 Receptor Agonists in Plastic Surgery: Perioperative Considerations and Safety Protocols"],"prefix":"10.7759","author":[{"given":"Rodrigo","family":"Davila Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Campos Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alfonso","family":"Diaz Fosado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Reyes Esparza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar A","family":"Perez Benitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S470826","article-title":"Clinical pharmacokinetics of semaglutide: a systematic review","volume":"18","author":"Yang XD","year":"2024","unstructured":"Yang XD, Yang YY. Clinical pharmacokinetics of semaglutide: a systematic review. Drug Des Devel Ther. 2024, 18:2555-70. 10.2147\/DDDT.S470826","journal-title":"Drug Des Devel Ther"},{"key":"ref2","article-title":"Dulaglutide (Trulicity): the third once-weekly GLP-1 agonist","volume":"41","author":"Smith LL","year":"2016","unstructured":"Smith LL, Mosley JF II, Parke C, Brown J, Barris LS, Phan LD. Dulaglutide (Trulicity): the third once-weekly GLP-1 agonist. P T. 2016, 41:357-60.","journal-title":"P T"},{"key":"ref3","article-title":"Semaglutide","author":"Kommu S","year":"2024","unstructured":"Kommu S, Whitfield P. Semaglutide. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref4","article-title":"Liraglutide","author":"Cerillo JL","year":"2024","unstructured":"Cerillo JL, Parmar M. Liraglutide. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref5","article-title":"Tirzepatide","author":"Farzam K","year":"2024","unstructured":"Farzam K, Patel P. Tirzepatide. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng Z","year":"2024","unstructured":"Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, Gao J. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024, 9:234. 10.1038\/s41392-024-01931-z","journal-title":"Signal Transduct Target Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0417","article-title":"Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial","volume":"41","author":"Ahmann AJ","year":"2018","unstructured":"Ahmann AJ, Capehorn M, Charpentier G, et al.. Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial. Diabetes Care. 2018, 41:258-66. 10.2337\/dc17-0417","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.14752","article-title":"Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes: a randomized clinical trial","volume":"318","author":"Davies M","year":"2017","unstructured":"Davies M, Pieber TR, Hartoft-Nielsen ML, Hansen OK, Jabbour S, Rosenstock J. Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes: a randomized clinical trial. JAMA. 2017, 318:1460-70. 10.1001\/jama.2017.14752","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00068-7","article-title":"Semaglutide 2\u00b74 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial","volume":"8","author":"Loomba R","year":"2023","unstructured":"Loomba R, Abdelmalek MF, Armstrong MJ, et al.. Semaglutide 2\u00b74 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2023, 8:511-22. 10.1016\/S2468-1253(23)00068-7","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia","volume":"159","author":"Sen S","year":"2024","unstructured":"Sen S, Potnuru PP, Hernandez N, Goehl C, Praestholm C, Sridhar S, Nwokolo OO. Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia. JAMA Surg. 2024, 159:660-7. 10.1001\/jamasurg.2024.0111","journal-title":"JAMA Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/anae.16454","article-title":"Relationship between residual gastric content and peri-operative semaglutide use assessed by gastric ultrasound: a prospective observational study","volume":"79","author":"Nersessian RS","year":"2024","unstructured":"Nersessian RS, da Silva LM, Carvalho MA, et al.. Relationship between residual gastric content and peri-operative semaglutide use assessed by gastric ultrasound: a prospective observational study. Anaesthesia. 2024, 79:1317-24. 10.1111\/anae.16454","journal-title":"Anaesthesia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-023-02440-3","article-title":"Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report","volume":"70","author":"Klein SR","year":"2023","unstructured":"Klein SR, Hobai IA. Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report. Can J Anaesth. 2023, 70:1394-6. 10.1007\/s12630-023-02440-3","journal-title":"Can J Anaesth"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/anr3.12278","article-title":"Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss","volume":"12","author":"Avraham SA","year":"2024","unstructured":"Avraham SA, Hossein J, Somri F, Hawash N, Hochman O. Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss. Anaesth Rep. 2024, 12:e12278. 10.1002\/anr3.12278","journal-title":"Anaesth Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S506957","article-title":"A comprehensive review on the pharmacokinetics and drug-drug interactions of approved GLP-1 receptor agonists and a dual GLP-1\/GIP receptor agonist","volume":"19","author":"Min JS","year":"2025","unstructured":"Min JS, Jo SJ, Lee S, Kim DY, Kim DH, Lee CB, Bae SK. A comprehensive review on the pharmacokinetics and drug-drug interactions of approved GLP-1 receptor agonists and a dual GLP-1\/GIP receptor agonist. Drug Des Devel Ther. 2025, 19:3509-37. 10.2147\/DDDT.S506957","journal-title":"Drug Des Devel Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s44158-025-00237-y","article-title":"A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia","volume":"5","author":"Vetrugno L","year":"2025","unstructured":"Vetrugno L, Deana C, Da Porto A, Boero E, Bellini V, Biasucci DG, Bignami EG. A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia. J Anesth Analg Crit Care. 2025, 5:16. 10.1186\/s44158-025-00237-y","journal-title":"J Anesth Analg Crit Care"},{"key":"ref16","unstructured":"American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists. (2023). https.\/\/www.asahq.org\/about-asa\/newsroom\/news-releases\/2023\/06\/american-society-of-anesthesiologists-consensus-based-...."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.10.003","article-title":"Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period","volume":"23","author":"Kindel TL","year":"2025","unstructured":"Kindel TL, Wang AY, Wadhwa A, et al.. Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Clin Gastroenterol Hepatol. 2025, 23:2083-5. 10.1016\/j.cgh.2024.10.003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000001452","article-title":"Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists task force on preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration","volume":"126","year":"2017","unstructured":"Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration. application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists task force on preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration. Anesthesiology. 2017, 126:376-93. 10.1097\/ALN.0000000000001452","journal-title":"Anesthesiology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000001914","article-title":"Glucagon-like peptide-1 receptor agonists in the perioperative period: implications for the anaesthesiologist","volume":"41","author":"Gariani K","year":"2024","unstructured":"Gariani K, Putzu A. Glucagon-like peptide-1 receptor agonists in the perioperative period: implications for the anaesthesiologist. Eur J Anaesthesiol. 2024, 41:245-6. 10.1097\/EJA.0000000000001914","journal-title":"Eur J Anaesthesiol"},{"key":"ref20","article-title":"Are serious anesthesia risks of semaglutide and other GLP-1 agonists under-recognized? Case reports of retained solid gastric contents in patients undergoing anesthesia","volume":"38","author":"Beam WB","year":"2023","unstructured":"Beam WB, Hunter Guevara LR. Are serious anesthesia risks of semaglutide and other GLP-1 agonists under-recognized? Case reports of retained solid gastric contents in patients undergoing anesthesia. Anesth Patient Saf Found Newslett. 2023, 38:","journal-title":"Anesth Patient Saf Found Newslett"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.09.008","article-title":"A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer","volume":"98","author":"Alves C","year":"2012","unstructured":"Alves C, Batel-Marques F, Macedo AF. A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer. Diabetes Res Clin Pract. 2012, 98:271-84. 10.1016\/j.diabres.2012.09.008","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/440959-glucagon-like-peptide-1-receptor-agonists-in-plastic-surgery-perioperative-considerations-and-safety-protocols","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T21:30:43Z","timestamp":1766439043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/440959-glucagon-like-peptide-1-receptor-agonists-in-plastic-surgery-perioperative-considerations-and-safety-protocols"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.99865","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,22]]}}}